Marigi Erick M, Alder Kareme D, Yu Kristin E, Johnson Quinn J, Marigi Ian M, Schoch Bradley S, Tokish John M, Sanchez-Sotelo Joaquin, Barlow Jonathan D
Department of Orthopedic Surgery, Mayo Clinic, Jacksonville, FL, USA.
Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
JSES Rev Rep Tech. 2025 Jan 23;5(2):146-153. doi: 10.1016/j.xrrt.2024.12.012. eCollection 2025 May.
Within orthopedic surgery, there remain limited data evaluating the impact of racial and socioeconomic disparities on outcomes of primary shoulder arthroplasty (SA) over time. As such, we analyzed both short- and longer-term outcome differences in complications, reoperations, and revision surgery of primary SA when performed in non-White patients when compared to a matched cohort of White patients who had undergone SA.
Over a 39-year period (1981-2020), an institutional Total Joint Registry Database was utilized to identify all non-White patients (Asian/Pacific Islander, Black, Hispanic or Latino, American Indian/Alaska Native, other) who underwent primary SA with a minimum of 2 years of follow-up. The search identified 275 primary SA (46 hemiarthroplasties, 97 anatomic total shoulder arthroplasties, and 132 reverse total shoulder arthroplasties). The ethnicity composition was 8.7% Asian, 27.3% Black, 37.8% Hispanic, 12.4% American Indian, and 13.8% other. This cohort was matched 1:2 according to age, sex, diagnosis, implant, and surgical year to a control group of 550 White patients who had undergone SA. The rates of medical and surgical complications, reoperations, revisions, and implant survivorship were assessed. The mean follow-up time was 6.3 years (range, 2 to 40 years).
Comparisons between the non-White and White matched cohorts demonstrated a higher rate of tobacco use (14.2% vs. 10.5%; < .001), diabetes (21.5% vs. 11.8%; < .001), length of stay (1.9 vs. 1.6 days; = .014), and a lower rate of private commercial insurance (27.3% vs. 44.5%; < .001 in the non-White cohort. Within the first 90 days after surgery, non-White patients had a higher rate of emergency department visits (5.5% vs. 0.9%; < .001) and unplanned readmissions (2.9% vs. 0.7%; = .014). After the first 90 postoperative days, there were no differences regarding medical (1.8% vs. 0.7%; = .135) or surgical complications (12.0% vs. 13.6%; = .446). Ten-year survivorship free of all-cause complication (76.8% vs. 81.5%; = .370), reoperation (84.9% vs. 89.8%; = .492), and revision (89.3% vs. 91.4%; = .715) were similar between the non-White and White cohorts.
After accounting for age, sex, and surgical indication, patient race and ethnicity were not associated with an increased risk of long-term all-cause complications, reoperations, or revision surgery after primary SA. However, within the first 90 postoperative days, non-White patients had a higher likelihood of unplanned emergency room visits and readmissions.
在骨科手术领域,长期以来评估种族和社会经济差异对初次肩关节置换术(SA)结果影响的数据有限。因此,我们分析了非白人患者与接受SA的匹配白人患者队列相比,在初次SA的并发症、再次手术和翻修手术方面的短期和长期结果差异。
在39年期间(1981 - 2020年),利用机构全关节注册数据库识别所有接受初次SA且至少随访2年的非白人患者(亚洲/太平洋岛民、黑人、西班牙裔或拉丁裔、美洲印第安人/阿拉斯加原住民、其他)。搜索共识别出275例初次SA(46例半关节置换术、97例解剖型全肩关节置换术和132例反置全肩关节置换术)。种族构成包括8.7%亚洲人、27.3%黑人、37.8%西班牙裔、12.4%美洲印第安人以及13.8%其他种族。该队列按照年龄、性别、诊断、植入物和手术年份以1:2的比例与550例接受SA的白人患者对照组进行匹配。评估了医疗和手术并发症、再次手术、翻修以及植入物生存率。平均随访时间为6.3年(范围2至40年)。
非白人匹配队列与白人队列的比较显示,非白人队列中吸烟率更高(14.2%对10.5%;P <.001)、糖尿病患病率更高(21.5%对11.8%;P <.001)、住院时间更长(1.9天对1.6天;P =.014),而私人商业保险覆盖率更低(27.3%对44.5%;非白人队列中P <.001)。在术后前90天内,非白人患者急诊就诊率更高(5.5%对0.9%;P <.001)以及非计划再入院率更高(2.9%对0.7%;P =.014)。术后9